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Abstract
Background: The ovulatory gonadotropin surge increases synthesis of prostaglandin E2 (PGE2) by the
periovulatory follicle. PGE2 actions on granulosa cells are essential for successful ovulation. The aim of the present
study is to determine if PGE2 also acts directly at the oocyte to regulate periovulatory events.
Methods: Oocytes were obtained from monkeys and mice after ovarian follicular stimulation and assessed for
PGE2 receptor mRNA and proteins. Oocytes were cultured with vehicle or PGE2 and assessed for cAMP generation,
resumption of meiosis, and in vitro fertilization.
Results: Germinal vesicle intact (GV) oocytes from both monkeys and mice expressed mRNA for the PGE2
receptors EP2, EP3, and EP4. EP2 and EP4 proteins were detected by confocal microscopy in oocytes of both
species. Monkey and mouse oocytes responded to PGE2 as well as agonists selective for EP2 and EP4 receptors
with elevated cAMP, consistent with previous identification of EP2 and EP4 as Gas/adenylyl cyclase coupled
receptors. Incubation of mouse GV stage oocytes with PGE2 delayed oocyte nuclear maturation in vitro, but PGE2
treatment did not alter the percentage of mouse oocytes that fertilized successfully. PGE2 treatment also decreased
the percentage of monkey oocytes that resumed meiosis in vitro. In contrast with mouse oocytes, the percentage
of monkey oocytes which fertilized in vitro was lower after treatment with PGE2. Monkey oocytes with intact
cumulus showed delayed nuclear maturation, but fertilization rate was not affected by PGE2 treatment.
Conclusions: Monkey and mouse oocytes express functional PGE2 receptors. PGE2 acts directly at mammalian
oocytes to delay nuclear maturation. Surrounding cumulus cells modulate the effect of PGE2 to alter subsequent
fertilization.
Background
The ovulatory surge of luteinizing hormone (LH) stimu-
lates events within the dominant ovarian follicle which
lead to ovulation. One such action of LH is to increase
PGE2 levels within the follicle [1]. PGE2 stimulates ovu-
latory events such as expansion of cumulus granulosa
cells and enhanced expression of proteases associated
with follicle rupture [2]. Blockade of PGE2 production
within the follicle [3,4] or genetic manipulation which
disrupts PGE2 production or PGE2 receptor expression
[5,6] can prevent ovulation, further highlighting the
essential role of receptor-mediated actions of PGE2 in
mammalian ovulation.
PGE2 acts via G-protein coupled EP receptors [7].
Four distinct EP receptors (EP1, EP2, EP3, and EP4)
have been identified. To date, examination of follicular
EP receptor expression has focused on granulosa cells,
with both cumulus and mural granulosa cells shown to
express multiple types of EP receptors [8,9]. While
PGE2 acts at both cumulus and mural granulosa cells of
ovulatory follicles to promote periovulatory events
[10,11], comparatively little is known about the oocyte
as a target for PGE2 action. Detection of EP2 mRNA in
bovine oocytes has been reported [12]. In contrast, a
recent report suggests that mouse oocytes do not
express EP receptor proteins [10]. The purpose of this
study is to determine if the mammalian oocytes express
EP receptors capable of signal transduction and modula-
tion of oocyte function. * Correspondence: lchristenson@kumc.edu
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Monkey studies
Oocytes
Oocytes were obtained from adult female cynomolgus
macaques (Macaca fascicularis) at Eastern Virginia Med-
ical School (EVMS). All animal protocols were approved
by the EVMS Animal Care and Use Committee and
were conducted in accordance with the NIH Guide for
the Care and Use of Laboratory Animals. Adult females
with regular menstrual cycles were maintained as pre-
viously described and checked daily for menstruation;
the first day of menstruation was designated day 1 of
the menstrual cycle [13]. Blood samples were obtained
under ketamine chemical restraint (10 mg/kg body
weight) by femoral or saphenous venipuncture, and
serum was stored at -20°C.
A controlled ovarian stimulation model developed for
the collection of multiple oocytes for in vitro fertiliza-
tion was used as previously described [13]. Recombinant
human FSH (r-hFSH, 90 IU/day, Organon Pharmaceuti-
cals, a part of Schering-Plough, now Merck & Co.,
Whitehouse Station, NJ) was administered for 6-8 days,
followed by administration of r-hFSH plus r-hLH (Ser-
ono Reproductive Biology Institute, Rockland, MA, 60
IU/day) for 2-3 days to stimulate the growth of multiple
preovulatory follicles. A GnRH antagonist (Ganirelix (30
μg/kg body weight; Merck) or Antide (0.5 mg/kg body
weight; Serono)) was also administered daily to prevent
an endogenous ovulatory LH surge. Adequate follicular
development was monitored by serum estradiol levels
and ultrasonography [14]. At aseptic surgery, each folli-
cle was pierced with a 22-gauge needle, and the aspi-
rated contents of all follicles larger than 4 mm in
diameter were pooled.
In the laboratory, aspirates were subjected to centrifu-
gation to pellet the oocytes and granulosa cells. Cells
were resuspended in TALP-HEPES media and main-
tained at 37°C while oocytes were mechanically removed
[14]. For assessment of EP receptor mRNAs, oocytes
were treated with 1.0% hyaluronidase (weight/volume; w/
v) for 15 seconds [15], followed by 0.5% pronase (w/v) for
2 minutes, and then rinsed by several transfers through
clean medium to ensure granulosa cell removal. For
cAMP analysis and culture of oocyte without cumulus,
oocytes were treated with hyaluronidase only; remaining
granulosa cells were removed with Stripper tips (MidA-
tlantic Diagnostics, Mount Laurel, NJ), and removal of
granulosa cells was confirmed visually using a light
microscope. For immunofluorescent detection of EP
receptor proteins and culture of oocytes with intact
cumulus, cumulus-oocyte complexes were handled gently
to ensure that cumulus granulosa cells were not removed.
All oocytes examined in this study were collected at the
germinal vesicle (GV) stage of nuclear maturation.
Sperm
Adult male cynomolgus monkeys (Macaca fascicularis)
were housed at the California National Primate
Research Center (CNPRC) as described previously for
rhesus monkeys [16]. All procedures for maintenance
and handling of the animals were approved by the Insti-
tutional Animal Use and Care Administrative Advisory
Committee at the University of California at Davis.
Experiments were conducted in accordance with the
NIH Guide for Care and Use of Laboratory Animals.
Ejaculated semen samples were collected from 2 adult
males that were individually caged at the CNPRC with
lights on from 0600 to 1800 hours at 25°C to 27°C. The
males were trained to chair restraint, and semen was
collected by direct penile stimulation with a Grass 6
stimulator (Grass Medical Instruments, Quincy, Massa-
chusetts) equipped with electrocardiogram pad electro-
des (30-50 V, 20 ms duration, 18 pulses s-1) [17].
Samples were allowed to liquefy for 30 minutes before
processing.
The sperm cryopreservation method used was identi-
cal to that previously published for rhesus monkey
sperm [18]. In brief, a Styrofoam box (inside dimen-
sions: 33 × 24 × 23 cm) was filled with a depth of 4 cm
liquid nitrogen and a 1-cm-thick or 0.4-cm-thick Styro-
foam “boat” w a sf l o a t e do nt o po fi tf o r1 0m i n u t e s .
Straws were then placed on top of the “boat” for 10
minutes before being plunged into liquid nitrogen. The
extender used was TEST-20% yolk-3% glycerol (w/v).
The average cooling rate from -10°C to -70°C was about
220°C min-1 for the 1-cm boat.
Reverse transcription-PCR (RT-PCR)
Total RNA was obtained from 1-3 oocytes/monkey
using Trizol reagent (Invitrogen, Rockville, MD) and
concentrated to 1 μl final volume with vacuum concen-
tration. One μlo f1μMT 7( d T ) 24 promoter primer
(5’GGCCAGTGAATTGTAATACGACTCACTATAGG-
GAGGCGGTTTTTTTTTTTTTTTTTTTTTTTT 3’)
was annealed at 70°C for 6 minutes. First strand and
second strand cDNA synthesis was performed using the
SuperScript II Choice Reverse Transcription system
(Invitrogen). Following ammonium acetate precipitation,
the cDNA was resuspended in 4 μln u c l e a s ef r e ew a t e r
and in vitro-transcribed using the MegaScript T7 kit
(Ambion) for 5 hours. The amplified cDNA was purified
using the RNA clean-up procedure from the RNeasy
Mini purification kit (Qiagen). Purified cDNA was
vacuum concentrated and reverse transcribed as
described previously [19].
Multiple mRNAs were analyzed in each monkey
oocyte preparation by RT-PCR using a Roche LightCy-
cler (Indianapolis, IN). PCR was performed using the
FastStart DNA Master SYBR Green I kit (Roche). Pri-
mers for amplification of EP receptor cDNAs were
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LightCycler Probe Design software (Roche); PCR pri-
mers, reaction conditions, and monkey sequence acces-
sion numbers were previously published [8]. b-actin
mRNA was also detected by PCR to ensure successful
amplification of each oocyte preparation. To ensure that
oocytes were free of granulosa cells, only preparations
negative for aromatase mRNA (expressed by cumulus
granulosa cells but not oocytes [20]) were used for
assessment of EP mRNAs. Intra- and inter-assay coeffi-
cients of variation for RT-PCR were less than 10%.
Immunofluorescent detection of EP receptors
Oocytes with attached cumulus cells were fixed in 4%
paraformaldehyde (w/v) in phosphate buffered saline, pH
7.4 (PBS) for 20 min at room temperature. After washing
in PBS, oocytes were blocked by incubation in PBS con-
taining 0.1% Triton-X100 (volume/volume; v/v) and 5%
goat serum (v/v; Vector Laboratories, Burlingame, CA)
for 1 hour at room temperature then overnight at 4C.
Primary antibody directed against a single EP receptor
(2.0 μg/ml, rabbit polyclonal, Cayman Chemical, Ann
Arbor, MI) was prepared in PBS+0.1% Triton-X100;
oocytes were incubated in primary antibody solution for
2 hours at room temperature, washed in PBS, then incu-
bated in Alexa-Fluor 488-conjugated secondary antibody
directed against rabbit IgG (1:1000 dilution in PBS+0.1%
Triton-X100, Molecular Probes, Eugene, OR) for 1 hour
at room temperature before washing in PBS and mount-
ing in aqueous mounting medium (Vectashield, Vector).
Either propidium iodide or DAPI was included in the
mounting medium to stain DNA and aid in locating
oocytes for microscopy. In each experiment, the primary
antibody was omitted for at least one oocyte such that
these oocytes were incubated with PBS+0.1% Triton
X-100 only. In other experiments, the primary antibody
was preabsorbed with the peptide used to generate the
antibody (2 μg/ml antibody + 6-10 μg/ml peptide;
Cayman) for 2 hours at room temperature before incuba-
tion with oocytes.
Monkey oocytes were imaged using a Zeiss 510 scan-
ning laser confocal microscope with LSM5 software for
image acquisition (Carl Zeiss, Inc. Thornwood, NY).
Fluorescent imaging was performed using 488 nm exci-
tation with a 505/550 band-pass filter to image EP
receptor fluorescence with gain of 595. Each oocyte was
imaged as a Z-stack of approximately 20 images, each
0.5 μm in thickness. Two oocytes from each of a mini-
mum of 3 animals were imaged for each primary anti-
body; 1 oocyte incubated with no primary antibody was
imaged for each animal. For each primary antibody
used, preabsorption was performed with oocytes posses-
sing attached cumulus cells from at least 1 animal. Suc-
cessful detection of all EP proteins in monkey kidney
with these primary antibodies as well as elimination of
immunofluorescence with preabsorption was previously
reported [8].
Cyclic AMP generation
Monkey oocytes (6-10/group) were placed in 50 μl
d r o p so fT A L Pm e d i u m[ 1 4 ]c ontaining either PGE2
(10
-6M, Cayman), the EP2 selective agonist butaprost
(10
-5M, Cayman), the EP4 selective agonist PGE1 alco-
hol (10
-7M, Cayman), or vehicle (0.06% DMSO; v/v). EP
receptor agonist concentrations were selected to achieve
maximal receptor occupancy while minimizing interac-
tion with nontargeted EP receptors [7,8]. Oocytes with-
out cumulus were cultured under oil in a humidified
cell culture incubator (37°C, 5% O2, 95% CO2) for 3
hours. Media + oocytes was stored at -20°C until
assayed for cAMP by EIA (Cayman) using the acetyla-
tion protocol according to manufacturer’s instructions.
Intra- and inter-assay coefficients of variation were
11.6% and 11.2%, respectively. Data are expressed as
fmol cAMP/oocyte.
No granulosa cells were seen attached to oocytes prior
to initiation of cAMP generation experiments. Prelimin-
ary experiments confirm that cAMP generation by con-
taminating granulosa cells cannot account for cAMP
measured in oocyte cultures. Granulosa cells cultured in
the absence of EP agonists produced approximately 1 ×
10
-19 mol cAMP/cell·hour, while cells cultured in the
presence of PGE2 produced approximately 3 × 10
-19
mol cAMP/cell·hour, indicating that contamination with
about 10,000 cells/50 μld r o po fT A L Pm e d i u mw o u l d
be needed to produce cAMP as measured in oocyte
cultures.
In vitro maturation and fertilization of monkey oocytes
Oocytes were cultured in media containing PGE2 or
vehicle (DMSO) as described for cAMP generation.
After 30 hours in vitro, the stage of nuclear maturation
(germinal vesicle (GV), germinal vesicle break down
(GVBD), or meiosis II (MII) was recorded. Each oocyte
was moved to a fresh drop of TALP medium (without
PGE2 or vehicle) for in vitro fertilization. Semen from
cynomolgus macaques was thawed, washed, and acti-
vated as previously described [21,22]. Hypermotile
sperm (10,000 per oocyte) were added to each drop of
media. The next morning (about 20 hours later), oocytes
were moved to fresh drops of media without PGE2 or
vehicle and observed each day for the next 2 days. Ferti-
lization was assessed by observation of a second polar
body. Cleavage to form an embryo of 2 or more cells
w a sa l s on o t e d .E m b r y o sw e r es t a i n e dw i t hD A P It o
confirm that each cell contained DNA (not shown).
Mouse studies
Animals
CF1 female mice aged 19-21 days old and B6D2F1
males aged 3-6 months were purchased from Harlan
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and light-controlled room on a 14 hour light: 10 hour
dark cycle. Experiments were approved by the University
of Kansas Medical Center Animal Care and Use Com-
mittee and conducted in accordance with the NIH
Guide for the Care and Use of Laboratory Animals.
In vitro maturation and fertilization of mouse oocytes
Female mice were stimulated with 5 IU equine chorionic
gonadotropin (eCG; Calbiochem, San Diego CA USA).
Ovaries were collected at 42-46 hours post-eCG at sacri-
fice by isofluorothane inhalation anesthesia followed by
cervical dislocation. Cumulus-enclosed oocytes were
released from large antral follicles into HEPES-buffered
KSOM (FHM, Chemicon-Millipore, Billerica MA) and 4
mg/ml BSA (mFHM). Cumulus cells were manually
stripped by repeated pipetting with a pulled glass
pipette.
In vitro maturation was performed as previously
described in K-MAT medium (KSOM
AA medium supple-
mented on the day of cultures with 1 mM glycyl-glutamine,
0.23 mM pyruvate, 4 mg/ml BSA, 0.6 mM L-cysteine,
0.5 mg/ml D-glucosamine, 0.02 μM ascorbate, 0.1% insu-
lin-transferrin-selenium (ITS; Sigma Corp, St Louis MO;
v/v), and 10 ng/ml EGF (Calbiochem, San Diego CA)) [23].
Drops (50 μl) of in vitro maturation culture media were
overlayed with embryo tested mineral oil (0.2 μm sterile fil-
tered and stored in the dark). Mouse oocytes and embryos
were cultured in an incubator at 37.2°C in 6% CO2 in
humidified air.
Methods for in vitro maturation, in vitro fertilization,
and embryo culture were modifications of those pre-
viously published [24,25]. Briefly, oocytes were matured
for 17 hours in K-MAT medium supplemented with
either vehicle or PGE2. To prevent zona hardening, 1
mg/ml of dialyzed Fetuin [26,27] and 1% FBS (v/v) were
added to the FHM collection medium and the in vitro
maturation culture media. Sperm were collected from
the caudal epididymis of B6D2 F1 males and capacitated
in modified Tyrodes medium for 90-120 min prior to
fertilization. Following in vitro maturation, oocytes were
transferred into mKSOM
aa medium (KSOM medium
with 1/2× essential and non-essential amino acids, 5.5
mM glucose and 4 mg/ml BSA and capacitated sperm
were added (1 × 10
6/ml). Eggs were removed from the
fertilization dishes after 6 hours of sperm exposure and
checked for pronuclei, gently washed to remove loose
sperm, and cultured in 50 μld r o p so fm K S O M
aa under
oil. After 24 hours of culture, eggs were examined for
cleavage to 2 cells. All 2-cell embryos were washed and
transferred to fresh culture plates of mKSOM
aa to
remove the dead sperm. Embryo development was eval-
uated at 120 hours after sperm addition, and progres-
sion to blastocyst formation and zona hatching was
recorded.
Immunofluorescent detection of EP receptors
Methods for fixation and immunohistochemistry were
similar to those previously reported [28]. Briefly, oocytes
with minimal cumulus cells were fixed for 10 min at room
temperature in FHM medium with 3% paraformaldehyde
(w/v) followed by 30 min at 35°C in microtubule stabiliza-
tion buffer with 2% formalin (w/v). After fixation, eggs and
embryos were permeabilized for 5 min in 0.1% Triton-
X100 (v/v) in wash solution [28]. Primary antibodies for
EP receptor localization were as described for monkey
oocytes. Oocytes were incubated with primary antibodies
overnight at 4°C followed by secondary antibody for 2
hours at 35°C. Oocytes were then transferred to wash
solution containing 10 μg/ml Hoechst 33258 (DNA) with
1:100 phalloidin-Alexa 568 (f-actin; Molecular Probes-
Invitrogen, Carlsbad, CA) for 1 hour and mounted on
glass slides (mounting medium consisted of 1:1 glycerol:
PBS supplemented with 5 mg/ml sodium azide and 10 μg/
ml Hoechst 33258). All blastocysts were fixed for 30 min
in 2% paraformaldehyde (w/v) in PBS (pH 7.4) and labeled
for 1 hour with 1:100 Calponin-3 (Santa Cruz Biotech,
Santa Cruz CA) to label the inner cell mass, followed by 1
hour with goat anti-mouse Alexa-488 secondary then 30
min with Hoechst 33258 and phalloidin-Alexa 568.
Oocytes and embryos were imaged immediately after
staining. Serial z-sections (1 μm depth) were obtained
using a Zeiss Pascal confocal microscope.
RT-PCR
Total RNA was isolated from oocytes using Trizol reagent
and was reverse transcribed using random primers [29].
The resulting cDNA was amplified in PCR reactions using
primers specific to murine EP1, EP2, EP3 and EP4 and
Power Sybr Green Master Mix (Applied Biosystems).
GAPDH and 18 S Taqman primers and probe sets
(Applied Biosystems) were used to confirm the relative
amounts of cDNA within the samples. The primer pairs
used are as follows: EP1, forward: 5’-GCAGCACTGGCCC
TCTTG-3’;r e v e r s e :5 ’-TGTGCCATTATCGCCTGTTG-3’;
EP2, forward: 5’-GCCTTTCACAATCTTTGCCTACAT- 3’,
reverse: 5’-GACCGGTGGCCTAAGTATGG-3’; EP3, for-
ward: 5’-GGTCGCCGCTATTGATAATGA -3’,r e v e r s e :
5’-TCCCATCTGTGTCTTGCATTG -3’;a n dE P 4 ,f o r -
ward: 5’-GCTCGTGGTGCGAGTGTT-3’,r e v e r s e :5 ’-CT
GGGTTTCTGCTGATGTCTTTC-3’. In all cases, primer
pairs were designed to span an intron to prevent amplifi-
cation of genomic DNA. Additionally, dissociation curves
were performed to monitor for potential non-specific
amplifications. The standard cycling conditions were 50°
C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°
C for 15 sec and 60°C for 1 min.
Cyclic AMP generation
Denuded oocytes were transferred to oocyte maturation
medium supplemented with one of 4 treatments (10
-6M
PGE2, 10
-5M butaprost, 10
-7M PGE1 alcohol, or vehicle
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oocytes were then stored at -20°C until processed for
determination of cAMP as described for monkey
oocytes above.
Data analysis
Data were assessed for heterogeneity of variance using
Bartlett’s test. Cyclic AMP data were log transformed
prior to analysis. Cyclic AMP data as well as monkey
oocyte maturation data were analyzed by ANOVA, fol-
lowed by posthoc analysis with Duncan’sM u l t i p l e
Range Test. Comparisons of monkey oocyte maturation
between treatment groups, fertilization rates of monkey
oocytes, and progression of mouse oocytes to GVBD
were assessed by paired t-test. All parametric tests were
performed with StatPak v4.12 software (Northwest Ana-
lytical, Portland, OR). Mouse oocyte maturation and
embryonic development were assessed by Fisher’s exact
test (Prism 4.01, Graphpad Software Inc., La Jolla, CA).
Significance was assumed at p < 0.05. Data are pre-
sented at mean ± standard error of the mean (SEM).
Results
EP expression in monkey oocytes
RNA obtained from monkey oocytes was assayed for
each EP receptor by RT-PCR. EP receptor mRNAs were
detected in the majority of monkey oocyte preparations
(Figure 1). Aromatase mRNA was not detected in any of
the 6 oocyte preparations (not shown), indicating that
granulosa cell contamination was not responsible for
detection of EP mRNAs in monkey oocytes.
Immunofluorescence and confocal microscopy were
used to detect individual EP receptor proteins in monkey
oocytes and determine the location of each EP receptor
within the oocyte.
EP2 receptor protein was detected in each oocyte exam-
ined. EP2 immunofluorescence was strong in the region of
the plasma membrane, with some immunofluorescence in
the central portion of the oocyte (Figure 2A, B, C). Serial
sections through an individual oocyte obtained by confocal
laser microscopy demonstrated that EP2 immunostaining
was present in patches on or near the oocyte surface.
Bright cytoplasmic immunofluorescence located near the
plasma membrane is consistent with the presence of EP2
in vesicles. Cumulus granulosa cells showed EP2 immuno-
fluorescence (Figure 2F), consistent with previous reports
of EP2 expression by cumulus cells [10] and serving as a
positive control.
EP4 receptor protein immunofluorescence was observed
at the periphery of the oocyte, consistent with the antici-
pated location of EP4 in the plasma membrane (Figure
2D). Bright cytoplasmic immunofluorescence located in
the oocyte cytoplasm near the plasma membrane is consis-
tent with the presence of EP4 in vesicles. Cumulus granu-
losa cells showed EP4 immunofluorescence (Figure 2G),
consistent with reports of EP4 expression by cumulus cells
[10] and serving as a positive control.
EP1 receptor protein was not detected in monkey
oocytes, with little or no immunofluorescence observed
after incubation with EP1 receptor antibody or EP1
receptor antibody preabsorbed with the antigenic pep-
tide (not shown). Specific immunofluorescent detection
of EP3 receptor protein in oocytes was also not
observed; diffuse fluorescence was observed throughout
t h eo o c y t ea n dw a so n l ys l i g h t l yd i m i n i s h e di nt h e
Figure 1 Detection of EP mRNA in monkey oocytes. Products of the expected size were obtained by RT-PCR for EP1 (203 base pair (bp)), EP2
(253 bp), EP3 (251 bp), EP4 (228 bp), and b-actin (270 bp). Amplified product was not obtained when water was substituted for reverse
transcribed monkey RNA. Position of DNA base pair standards shown on left (bp). Below gel, the number of oocyte preparations with detectable
EP receptor mRNA is shown out of the total of 6 preparations tested; b-actin mRNA was detected in all 6 preparations tested.
Duffy et al. Reproductive Biology and Endocrinology 2010, 8:131
http://www.rbej.com/content/8/1/131
Page 5 of 12Figure 2 Immunofluorescent detection of EP receptor proteins (green) in monkey and mouse oocytes.P a n e l sA - C .E P 2
immunofluorescence in representative serial sections through a single monkey oocyte demonstrating concentration of fluorescence at the
plasma membrane (arrows), with diffuse central staining. Panel D. EP4 immunofluorescence was present primarily concentrated at the monkey
oocyte plasma membrane, with limited central fluorescence; germinal vesicle did not stain as indicated with an asterisk (*). Immunofluorescent
detection of EP2 (F) and EP4 (G) in monkey cumulus granulosa cells is indicated by arrowheads. Immunofluorescence was reduced when
primary antibody for EP2 (Panel E) or EP4 (not shown) was preabsorbed with the antigenic peptide. Omission of a primary antibody resulted in
no staining (not shown). Panels H-J. Immunodetection of EP2 (H) and EP4 (I) in mouse oocytes (arrows) and surrounding cumulus (arrowheads).
Immunofluorescence representing detection of EP2 was observed throughout the oocyte cytoplasm, while EP4 immunofluorescence was
concentrated near the germinal vesicle (GV). Immunofluorescence was reduced in both oocytes and cumulus when the primary antibody for EP2
(J) or EP4 (not shown) was preabsorbed with the antigenic peptide; omission of the primary antibody yielded very low staining (not shown). For
both species, images are representative of a minimum of 2 oocytes from a minimum of 3 different animals. Bar in Panel C = 50 μm and should
be used for all Panels.
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antibody (not shown).
Monkey oocyte responses to EP receptor agonists
To determine if monkey oocytes express functional EP
receptors, GV stage oocytes stripped of cumulus granu-
losa cells were cultured with PGE2, the EP2 receptor
agonist butaprost, or the EP4 receptor agonist PGE1
alcohol. All three EP agonists increased cAMP levels in
oocyte cultures when compared with cultures receiving
vehicle only (Figure 3).
To determine if PGE2 can act directly at monkey
oocytes to alter oocyte nuclear maturation and fertiliza-
tion, oocytes obtained at the GV stage were stripped
of cumulus cells and cultured with PGE2 or vehicle
(Figure 4A). After 30 hours of culture, 45 ± 12% of vehi-
cle-treated oocytes reached the MII stage while only 15 ±
8% of the PGE2-treated oocytes reached MII (p < 0.05).
Because GVBD stage oocytes can continue nuclear
maturation in vitro [30], GVBD and MII stage oocytes
were transferred to fresh media without vehicle or PGE2
and exposed to sperm in vitro. All oocytes that reached
MII by morning were assessed for fertilization. A second
polar body, evidence of successful fertilization, was
observed in a higher percentage of vehicle-treated oocytes
when compared to PGE2-treated oocytes (Figure 4B).
To determine if intact cumulus cells alter oocyte
responses to PGE2, additional GV-stage oocytes were
cultured with intact cumulus in the presence of either
vehicle or PGE2 for 30 hours. 44 ± 6% of cumulus-
intact oocytes reached the MII stage during vehicle
treatment while only 11 ± 6% of cumulus-intact oocytes
reached the MII stage during PGE2 treatment (p < 0.05;
Figure 4C). Cumulus cells were then removed from
GVBD and MII stage oocytes by gentle pipetting.
Oocytes were transferred to fresh media without vehicle
or PGE2 and fertilized in vitro. Of the oocytes that
reached MII by morning, similar percentages of vehicle-
and PGE2-treated oocytes were successfully fertilized
(Figure 4D).
EP expression in mouse oocytes
T h ed a t ap r e s e n t e da b o v ei n d i c a t et h a to o c y t e sf r o ma
non-human primate species, the cynomolgus macaque,
express EP2 and EP4 receptors coupled to Gas. Exposure
to the endogenous hormone (PGE2) and ligands selective
Figure 3 C y c l i cA M Pg e n e r a t i o ni nr e s p o n s et oE Pr e c e p t o ra g o n i s t s . Germinal vesicle (GV) stage oocytes obtained from monkeys (6-10
oocytes/group) and mice (15-20 oocytes/group) were pooled and maintained in culture for 4 hours in the presence of vehicle, the EP2 selective
agonist butaprost, the EP4 selective agonist PGE1-OH, or PGE2. Media + oocytes were stored at -20°C until assayed for cAMP by EIA. Data are
expressed as fmol cAMP/oocyte. Within each species, data were analyzed by ANOVA and Duncan’s Multiple Range Test. Groups with different
letters are different, p < 0.05. Data are expressed as mean + SEM, n = 3-10 groups of oocytes/treatment.
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retrieved at the GV stage were maintained in culture with either vehicle or PGE2. A. Stage of oocyte nuclear maturation was assessed after 30
hours in culture as either GV intact, germinal vesicle break down (GVBD), or meiosis II (MII). B. Fertilization was expressed relative to the total
number of oocytes which reached the MII stage by the morning after sperm addition. Panels C-D. Oocytes with intact cumulus (10-12 oocytes/
animal; n = 3 animals) were cultured with vehicle or PGE2; cumulus was removed for assessment of nuclear maturation and fertilization. C. Stage
of oocyte nuclear maturation was assessed after 30 hours in culture. D. Fertilization was expressed relative to the total number of oocytes which
reached the MII stage by the morning after sperm addition. In Panels A-D, black bars represent vehicle-treated oocytes and grey bars represent
PGE2-treated oocytes. Data in Panels A and C were analyzed by ANOVA and Duncan’s Multiple Range Test. In Panel C, groups with different
letters are different. In Panels A and C, vehicle is different from PGE2 treatment as determined by paired t-test and indicated by an asterisk (*).
Data in Panels B and D were analyzed by paired t-test, and differences are indicated by an asterisk (*). Data are expressed as a percentage
(mean + SEM) of the total number of oocytes in each treatment group for each animal (cohort). For all tests, significance is assumed at p < 0.05.
Representative monkey embryo obtained from an oocyte treated in culture with PGE2 (Panel E).
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respectively) increased cAMP levels, and PGE2 influ-
enced nuclear maturation and fertilization rates of mon-
key oocytes in vitro.
Similarly, expression and function of EP receptors in
mouse oocytes were examined (not shown). EP3 and
EP4 mRNAs were detected by RT-PCR in all mouse
oocyte preparations examined (n = 3), and EP2 mRNA
was detected in 1 of 3 oocyte preparations. In contrast,
EP1 mRNA was not detected in any mouse oocyte pre-
paration examined (n = 3).
Interestingly, all mouse oocytes expressed EP2 and
EP4 proteins, though EP2 mRNA was only detectable
in 1 of 3 oocyte samples. Confocal laser microscopy
detected EP2 protein in the cytoplasm of oocytes
(Figure 2H). EP4 was also detected in mouse oocytes
and was located primarily near the oocyte nucleus
(Figure 2I). Cumulus granulosa cells showed EP2 and
EP4 immunofluorescence (Figure 2H), confirming pre-
vious reports and serving as a positive control [10].
EP1 and EP3 were not observed in mouse oocytes (not
shown), similar to results obtained with monkey
oocytes. Preabsorption of the primary antibody with
the corresponding peptide eliminated immunofluores-
cence (Figure 2J and not shown), and oocytes incu-
bated without primary antibody were also devoid of
immunofluorescence (not shown).
Mouse oocyte responses to EP receptor agonists
Mouse oocytes expressed functional EP receptors.
Mouse oocytes stripped of cumulus granulosa cells were
cultured with PGE2, butaprost, or PGE1 alcohol; all EP
agonists increased cAMP levels in oocyte cultures when
compared with cultures of oocytes treated with vehicle
only (Figure 3).
To determine if PGE2 treatment of culture mouse
oocytes altered nuclear maturation or fertilization,
oocytes obtained at the GV stage were maintained in
vitro with vehicle or PGE2. After 2 hours of culture,
86% of vehicle-treated oocytes had completed GVBD;
during this same culture period, 63% of PGE2-treated
oocytes completed GVBD, with a trend toward
decreased nuclear maturation with PGE2 treatment (p =
0.075; Figure 5). PGE2 treatment also resulted in signifi-
cantly decreased progression to MII after 18 hours in
vitro (Table 1). Similar percentages of vehicle- and
PGE2-treated oocytes fertilized successfully, formed
blastocysts, and hatched in vitro (Table 1).
Discussion
The present study demonstrates that mammalian
oocytes express functional receptors for PGE2. Multiple
EP receptor mRNAs were detected in monkey and
mouse oocytes, but only EP2 and EP4 receptor proteins
were consistently detected by immunofluorescence.
These discrepancies are reminiscent of our studies of EP
expression in monkey mural granulosa cells before
administration of the ovulatory gonadotropin stimulus,
when EP1 and EP4 mRNA were detected, but these EP
proteins were not detected by immunofluorescence [8].
EP3 and EP4 mRNA were detected in all mouse oocytes
Figure 5 Mouse oocyte maturation in vitro.M o u s eo o c y t e s
retrieved at the GV stage were maintained in culture with vehicle
or PGE2 for 2 hours and assessed for progression to GVBD. Data are
expressed as mean + SEM, n = 4 animals. Rate of progression to
GVBD in the presence of PGE2 tended to be lower than for vehicle-
treated oocytes by paired t-test, p = 0.075.
Table 1 Mouse oocyte in vitro maturation and
fertilization
Vehicle (%) PGE2 (%)
MII at 16 hours 53 69
MII at 18 hours 95 84
a
Fertilization (2 cells) 71 71
Blastocyst 57 63
Hatched blastocyst 29 37
Each observation represents the percentage of all oocytes in the indicated
treatment group. Oocytes were pooled from 2 animals, n = 36-69 oocytes per
treatment group.
aPercent of cohort which progressed to MII by 18 hours was
lower with PGE2 treatment, p < 0.05 by Fisher’s exact test.
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Page 9 of 12examined, while only 1 of 3 oocyte preparations had
detectable EP2 mRNA. A previous report suggested that
EP2 and EP4 receptors were present in the cumulus, but
not oocyte, of the mouse cumulus-oocyte complex [10].
Our detection of EP receptor proteins within the oocyte,
with inconsistent detection of EP mRNAs, might suggest
that cumulus cells are the source of these EP receptor
proteins. However, use of confocal microscopy in the
present study permitted localization of EP receptors spe-
cifically to oocytes of mice and monkeys, suggesting that
mammalian oocytes express receptors capable of direct
response to PGE2.
Previous studies by this laboratory and others focused
on granulosa cells as the primary target for PGE2 action
within the periovulatory follicle. Mural cells are well
established as expressing multiple EP receptors. Granu-
losa cells from monkey periovulatory follicles expressed
mRNA for all 4 EP receptors, with EP1, EP2, and EP3
receptor proteins detected by immunofluorescence [8].
Granulosa cells from human follicular aspirates were
reported to express mRNA for EP2 and EP4, while EP1
and EP3 mRNA were not detected [31]. The present
study confirmed that monkey and mouse cumulus gran-
ulosa cells expressed EP2 and EP4 receptor proteins.
Previously, Segi and colleagues used in situ hybridization
to successfully localize mRNA for EP2 and EP4 (but not
EP1 and EP3) to cumulus granulosa cells within mouse
periovulatory follicles [9]. More recently, EP2, EP3 and
EP4 mRNA and proteins were localized to mouse cumu-
lus cells [10]. While the present study shows that EP2
and EP4 receptor proteins are expressed by mouse
cumulus, further studies will be needed to confirm
expression of EP3 receptor proteins. It is possible that
cumulus cell expression of EP receptors changes in
response to the midcycle LH surge, which may explain
discrepancies between these studies. Recently, theca
cells have also been suggested as a target for PGE2
action, with detection of mRNA for EP2, EP3, and EP4
in bovine theca [32] and EP2 mRNA in mouse theca
cells [9]. Taken together, these findings support the con-
cept that multiple cell types within the periovulatory fol-
licle, including cumulus granulosa cells, mural granulosa
cells, theca cells, and now oocytes, are potential targets
for PGE2 action.
EP receptors utilize G proteins to mediate the effect of
PGE2 binding to these transmembrane receptors [7].
EP2 and EP4 are reported to couple exclusively with
Gas to activate adenylyl cyclase and increase intracellu-
lar cAMP. In both monkey and mouse oocytes, stimula-
tion of EP2 and EP4 receptors increased cAMP as
anticipated. The distribution of EP2 receptors at the sur-
face of monkey oocytes was patchy, while EP4 receptors
were distributed more uniformly around the surface of
monkey oocytes. Microdomains have been reported in
the vicinity of plasma membranes, wherein a receptor
associates with specific G proteins, membrane-associated
enzymes, and other components of the intracellular sig-
naling apparatus [33]. Microdomains present the possi-
bility that EP2 and EP4 receptors may preferentially
associate with different isoforms of adenylyl cyclase or
cAMP phosphodiesterases in oocyte plasma membranes.
In mouse oocytes, EP2 was localized throughout the
cytoplasm while EP4 was primarily perinuclear in loca-
tion. Although prostaglandin receptors are often located
in plasma membranes, presence of prostaglandin recep-
tors, including EP4, in perinuclear membranes has been
reported [34]. Since EP2 and EP4 receptors were differ-
entially distributed within monkey and mouse oocytes,
cAMP generated via each receptor may have a unique
function. Furthermore, species differences in EP2 and
EP4 distribution suggests that PGE2 may regulate differ-
ent functions in oocytes obtained from different mam-
malian species.
Stimulation of EP2 and EP4 receptors increased
oocyte cAMP levels. Levels of cAMP measured in this
study were similar to previous reports of basal, PGE1-,
and PGE2-stimulated cAMP in mouse and bovine
oocytes [35,36]. Many pathways have been suggested to
elevate oocyte cAMP levels, including ligand-indepen-
dent receptors coupled to Gas and adenylyl cyclase
[37,38], suppression of cAMP phosphodiesterase activity
to limit cAMP breakdown [39], and transfer from gran-
ulosa cells [40]. In vivo, cumulus cells surrounding
oocytes also express EP2 and EP4 receptors, and cAMP
generated within cumulus cells can move to the adjacent
oocyte through junctional complexes connecting these
cells. The actions of PGE2 on individual cell types
within the oocyte-cumulus complex are difficult to dis-
cern in vivo. However, these studies do support the
hypothesis that oocytes can respond directly to PGE2
via stimulation of EP2 and EP4 receptors to contribute
to oocyte cAMP concentrations.
Levels of cAMP within the oocyte are critical in the
control of resumption of meiosis. The present study
shows that PGE2 treatment delayed progression of
meiosis in mouse oocytes as well as in monkey oocytes
without and with surrounding cumulus. This observa-
tion is consistent with the concept that high cytoplasmic
cAMP within the oocyte prevents resumption of meio-
sis; low cAMP permits meiosis to continue [41]. Several
agents which increased adenylyl cyclase-generated
cAMP levels also delayed resumption of meiosis in
bovine oocytes without and with surrounding cumulus
[36]. When mouse oocytes were treated in vitro with
cholera toxin or PGE1, trends towards increased cAMP
and delayed resumption of meiosis have been reported
[35]. These findings, taken together with data from the
present study, suggest that elevated PGE2 within the
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more pronounced effects in species with longer intervals
between the midcycle LH surge and ovulation. This con-
cept is consistent with previous studies showing delayed
induction of COX-2 expression and prostaglandin
synthesis in follicles of species with long periovulatory
intervals [1,42-44].
Fertilization and subsequent embryonic development
of denuded mouse oocytes was not altered by PGE2
treatment. This finding is consistent with previous stu-
dies showing that in vitro fertilization rates for oocytes
stripped of surrounding cumulus cells were similar
between wild type mice and mice lacking EP2 receptor
expression [5]. Overall, elevated follicular PGE2 may
delay nuclear maturation somewhat, but PGE2 exposure
does not alter fertilization of mouse oocytes.
In contrast, PGE2 treatment of monkey oocytes with-
out surrounding cumulus had a negative impact on the
fertilization rate. Interestingly, PGE2 treatment of cumu-
lus-intact oocytes did not alter subsequent fertilization.
PGE2 treatment reduced oocyte nuclear maturation in
the absence and presence of surrounding cumulus, sug-
gesting that progression of meiosis is modulated by
PGE2 action directly at oocytes. In the context of the
periovulatory follicle, PGE2 action at EP receptors on
cumulus cells and elsewhere in the follicle may directly
or indirectly regulate critical maturational changes
within the oocyte which promote successful fertilization.
Conclusions
These data demonstrate that mammalian oocytes
express functional PGE2 receptors. Since PGE2 levels in
t h ef o l l i c l ei n c r e a s ei nr e s p o n s et ot h em i d c y c l eL H
surge, PGE2 likely reaches EP receptors on both the
oocyte and surrounding cumulus cells prior to ovula-
tion. The ability of PGE2 to delay oocyte maturation
was more pronounced in non-human primate oocytes
than in murine oocytes, suggesting that PGE2 may play
a physiologic role to slow oocyte maturation in species
with longer intervals between the LH surge and ovula-
tion. PGE2 may be one of several local signaling mole-
cules within the follicle which coordinate oocyte
maturation with the time of follicle rupture, ensuring
release of an optimally-mature oocyte at ovulation.
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